AADI
Aadi Bioscience, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
David J. Lennon
IPO Date
2018-02-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Aadi Bioscience, Inc.
CEO
David J. Lennon
IPO Date
2018-02-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 8,333,000 |
| $0.00 |
| 4 Mar 2025 | BALL BRYAN | See remarks | A-Award | Acquired | 100,000 | $2.40 |
| 4 Mar 2025 | BALL BRYAN | See remarks | M-Exempt | Acquired | 5,000 | $0.00 |
| 4 Mar 2025 | BALL BRYAN | See remarks | S-Sale | Disposed | 2,147 | $2.35 |
| 4 Mar 2025 | BALL BRYAN | See remarks | M-Exempt | Disposed | 5,000 | $0.00 |
| 4 Mar 2025 | Castelein Caley | director | A-Award | Acquired | 1,666,000 | $2.40 |
| 3 Mar 2025 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M-Exempt | Acquired | 6,750 | $0.00 |
| 3 Mar 2025 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | S-Sale | Disposed | 2,806 | $2.35 |
| 3 Mar 2025 | Giacobello Scott M. | CHIEF FINANCIAL OFFICER | M-Exempt | Disposed | 6,750 | $0.00 |